YOLFTbeta
BioPorto

BioPorto

BIOPOR · CO · Healthcare / Diagnostics & Research

0.996DKK-0.01 (-0.90%)

Price History

Full chart

Market Stats

Previous Close1.01
Open0.992
Day Range0.98 – 1.00
52-Week Range0.839 – 1.38
Volume443.12K
Market Cap534.70M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta1.38
50-Day Avg1.17
200-Day Avg1.08

About

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers to diagnose acute kidney injury; and antibodies to develop diagnostic immunoassays within disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease. The company also provides ready-to-use enzyme-linked immunosorbent assay (ELISA) kits to quantify NGAL in urine, plasma, and serum; and generic Rapid Assay Device (gRAD) for custom lateral flow assays. BioPorto A/S was founded in 1917 and is based in Hellerup, Denmark.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Carsten Buhl
  • Employees44
  • HeadquartersTuborg Havnevej 15, st., Hellerup, Denmark, 2900, Denmark
  • Websitehttps://bioporto.com

Leadership

  • Mr. Carsten BuhlGroup Chief Executive Officer · b. 1973
  • Ms. Gry Husby LarsenExecutive VP & Group Chief Legal Officer · b. 1980
  • Mr. Klaus Juhl WulffCFO & Executive VP · b. 1973
  • Dr. Jakob FeldingChief Science Officer
  • Ms. Hanne SogaardHead of Investor Relations
  • Ms. Jennifer ZondermanSenior Vice President of Global Marketing & Commercialization
  • Mr. Jeffrey N. HaasPresident & CEO of BioPorto Inc.

Financials

Income Statement

Currency: DKK1999-12-312000-12-312001-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.95M812.00K24.00K2.42M2.10M4.36M5.55M8.34M8.34M11.01M13.80M18.58M17.86M16.63M18.71M20.38M20.72M25.16M26.02M26.62M23.20M24.25M28.97M30.96M36.24M40.29M
Growth (%)--90.92%-97.04%+9987.50%-13.05%+107.22%+27.33%+50.16%0.00%+31.99%+25.38%+34.65%-3.91%-6.90%+12.52%+8.97%+1.65%+21.40%+3.42%+2.33%-12.84%+4.53%+19.44%+6.87%+17.07%+11.16%
Cost of Revenue----69.00K4.49M2.42M4.62M4.62M4.75M5.34M8.06M6.80M7.58M5.51M4.90M5.03M6.91M8.18M9.29M9.87M9.21M9.93M10.78M11.71M12.27M
Gross Profit------123.00K3.13M3.72M3.72M6.26M8.46M10.52M11.05M9.04M13.20M15.48M15.69M18.25M17.84M17.33M13.34M15.04M19.04M20.18M24.53M28.01M
Gross Margin------2.82%56.43%44.58%44.58%56.85%61.28%56.61%61.91%54.39%70.55%75.95%75.74%72.54%68.55%65.09%57.49%62.01%65.73%65.19%67.68%69.54%
Operating Expense------14.48M-11.53M16.78M17.76M22.27M21.87M23.38M24.93M28.84M28.45M28.24M40.74M54.74M59.62M91.63M76.93M80.30M96.92M80.35M99.98M114.11M
Operating Income----719.00K14.36M14.66M-13.06M-14.04M-16.02M-13.41M-12.86M-13.87M-19.80M-15.26M-12.76M-25.05M-36.49M-41.78M-74.30M-63.59M-65.25M-77.88M-60.16M-75.45M-86.09M
Operating Margin----34.16%329.09%263.94%-156.63%-168.41%-145.50%-97.17%-69.19%-77.67%-119.11%-81.56%-62.60%-120.88%-145.08%-160.60%-279.09%-274.05%-269.05%-268.83%-194.34%-208.18%-213.70%
EBITDA------10.71M-12.96M-13.13M-14.23M-15.55M-12.99M-12.88M-13.94M-19.62M-14.78M-12.44M-24.43M-36.45M-40.96M-70.94M-61.99M-58.47M-76.49M-57.89M-70.53M-84.56M
EBITDA Margin------245.51%-233.33%-157.37%-170.66%-141.24%-94.14%-69.28%-78.08%-118.01%-79.03%-61.01%-117.92%-144.92%-157.45%-266.47%-267.17%-241.05%-264.05%-186.99%-194.59%-209.90%
Net Income----105.00K-15.71M-16.98M-15.25M-14.26M-16.08M-14.30M-14.91M-14.70M-20.62M-12.93M-10.73M-22.80M-32.24M-38.05M-69.64M-61.56M-57.11M-75.92M-56.33M-68.24M-82.12M
Net Income Margin----4.99%-360.20%-305.82%-182.81%-171.03%-146.06%-103.61%-80.21%-82.32%-124.05%-69.10%-52.65%-110.04%-128.18%-146.25%-261.60%-265.31%-235.48%-262.08%-181.95%-188.29%-203.83%
R&D-----6.68M7.64M6.38M6.38M8.64M8.90M8.13M9.91M10.21M8.62M9.94M9.67M21.93M18.68M24.56M28.13M30.26M34.94M25.45M33.53M50.07M
R&D as % of Total Revenue-----153.19%137.63%76.52%76.52%78.51%64.51%43.74%55.50%61.43%46.06%48.79%46.67%87.18%71.79%92.24%121.21%124.75%120.60%82.20%92.52%124.28%
Interest Expense00000153.00K190.00K744.00K1.75M61.00K889.00K2.05M1.82M2.15M44.00K311.00K77.00K106.00K113.00K451.00K845.00K912.00K1.21M642.00K834.00K772.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%3.51%3.42%8.92%20.92%0.55%6.44%11.02%10.18%12.91%0.24%1.53%0.37%0.42%0.43%1.69%3.64%3.76%4.16%2.07%2.30%1.92%

Balance Sheet

Currency: DKK1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.48M7.46M3.45M146.00K80.98M81.27M14.46M4.80M33.90M19.16M20.22M20.97M21.25M18.18M51.84M37.24M48.99M50.64M65.60M66.20M42.68M140.29M81.25M108.64M89.81M96.01M93.18M
Total Liabilities13.76M6.56M4.01M2.33M14.40M14.30M17.52M22.42M4.45M3.65M4.81M17.66M17.31M19.33M8.98M8.55M4.51M6.35M9.54M10.00M17.36M39.37M35.29M38.42M29.65M28.23M30.17M
Total Equity-894.00K--66.58M66.97M-3.06M-17.62M29.45M15.50M15.41M3.31M3.94M-1.15M42.86M28.69M44.48M44.29M56.07M56.20M25.32M100.91M45.96M70.22M60.16M67.78M63.01M
Cash31.00K481.00K1.18M1.00K12.44M3.25M4.34M4.10M27.49M12.91M14.34M13.93M14.11M8.35M42.80M25.45M34.87M35.64M47.08M46.71M18.12M107.94M45.52M81.79M66.40M59.66M54.89M
Total Debt-------4.03M---16.05M15.55M13.23M123.00K105.00K86.00K64.00K182.00K141.00K3.71M10.68M13.03M10.64M7.25M11.19M7.52M
Net Debt-------4.34M-69.00K-27.49M-12.91M-14.34M2.13M1.45M4.88M-42.68M-25.34M-34.78M-35.58M-46.90M-46.57M-14.41M-97.26M-32.49M-71.15M-59.15M-48.47M-47.37M

Cash Flow

Currency: DKK1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-503.00K-----13.88K-13.46K-14.13M-13.72M-13.29M-13.38M-13.61M-15.28M-16.64M-16.14M-16.57M-19.66M-29.40M-38.01M-60.16M-35.62M-64.58M-52.48M-55.46M-83.58M-77.07M
Investing Cash Flow-5.33M4.00M----516.00K-69.00K-738.00K-361.00K-23.00K-207.00K-30.00K-87.00K-33.00K-1.20M-517.00K-401.00K-59.00K-1.48M-2.06M-1.52M-412.00K-503.00K-277.00K1.19M1.27M
Financing Cash Flow----80.50M-20.40K248.00K46.38M-508.00K14.75M13.17M13.81M9.61M51.13M-18.00K26.51M20.84M40.90M39.12M33.61M127.03M1.10M88.70M40.79M75.47M71.94M
Capital Expenditure53.00K000163.00K412.00K251.00K265.00K880.00K392.00K14.00K201.00K23.00K82.00K28.00K807.00K514.00K357.00K38.00K1.46M1.11M1.50M389.00K471.00K39.00K350.00K0
Free Cash Flow-------264.88K-278.46K-15.01M-14.11M-13.30M-13.58M-13.63M-15.36M-16.67M-16.95M-17.09M-20.02M-29.44M-39.47M-61.27M-37.12M-64.97M-52.96M-55.49M-83.93M-77.07M
FCF to OCF------1908.23%2069.38%106.23%102.86%100.11%101.50%100.17%100.54%100.17%105.00%103.10%101.82%100.13%103.85%101.84%104.21%100.60%100.90%100.07%100.42%100.00%

Earnings

Report DateJun 30, 2008Sep 30, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015May 4, 2016Aug 4, 2016Nov 3, 2016Mar 15, 2017May 4, 2017Aug 10, 2017Nov 7, 2017Mar 8, 2018May 3, 2018Aug 16, 2018Nov 8, 2018Feb 22, 2019May 9, 2019Aug 15, 2019Nov 21, 2019Feb 26, 2020May 7, 2020Aug 19, 2020Nov 18, 2020Mar 17, 2021May 12, 2021Aug 18, 2021Nov 17, 2021May 11, 2022Aug 17, 2022Nov 9, 2022Mar 30, 2023May 10, 2023Aug 1, 2023Nov 1, 2023Feb 22, 2024May 8, 2024Aug 15, 2024Nov 14, 2024Mar 20, 2025May 8, 2025Aug 15, 2025Nov 20, 2025Mar 26, 2026Aug 20, 2026
EPS Estimate--------------------------------------0.06-0.06-0.06-0.07-0.07-0.07-0.06-0.07-0.06-0.06-0.07-0.06-0.07-0.07-0.05-0.06-0.07-0.05-0.05-0.04-0.03-0.03-0.03-0.05-0.03-0.05-0.05---
EPS Actual-0.05-0.04-0.05-0.06-0.05-0.05-0.04-0.04-0.04-0.05-0.02-0.07-0.03-0.05-0.04-0.06-0.05-0.07-0.03-0.02-0.03-0.01-0.01-0.02-0.02-0.01-0.01-0.03-0.04-0.04-0.02-0.04-0.04-0.04-0.03-0.05-0.06-0.07-0.04-0.07-0.10-0.12-0.09-0.09-0.08-0.09-0.06-0.06-0.05-0.04-0.06-0.05-0.05-0.08-0.05-0.05-0.03-0.02-0.04-0.04-0.05-0.04-0.06-0.04-0.05-0.030.07
Surprise--------------------------------------16.67%33.33%-15.00%-42.86%-71.43%-28.57%-46.50%-14.29%-50.00%0.00%14.29%16.67%42.86%14.29%0.00%16.67%-14.29%0.00%0.00%25.00%33.33%-33.33%-33.33%0.00%-33.33%-20.00%20.00%---
Timing---------------------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---

Key Statistics & Ratios

Market Cap534.70M
Enterprise Value478.47M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales13.94
Price / Book6.64
EPS-0.01
Book Value0.166
Revenue (TTM)38.37M
Gross Profit (TTM)29.50M
EBITDA-13.03M
Profit Margin-46.83%
Operating Margin504.07%
Return on Equity-25.74%
Return on Assets-8.65%
Shares Outstanding495.10M
Shares Float458.86M
Beta1.38
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 1, 2023654:629
  • Sep 28, 2020356:299
  • Mar 19, 2020296:291
  • Aug 20, 2013845:638